Joanna Perła-Kaján
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joanna Perła-Kaján has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Hieronim Jakubowski
Department of Microbiology, Biochemistry and Molecular Genetics, International Center for Public Health, New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA
20 shared publications - Olga Utyro
Poznan University of Life Sciences, Poznan, Poland
4 shared publications - Agata Malinowska
Mass Spectrometry Laboratory, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland
3 shared publications Tomasz Twardowski
Polish Academy of Sciences
3 shared publications- Łukasz Marczak
Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704, Poznan, Poland
3 shared publications Anetta Undas
New Jersey Medical School
2 shared publications
Latest Publications
- Open Access
- 3 August 2026
- Published by Springer Nature in Amino Acids
High-field asymmetric waveform ion mobility spectrometry (FAIMS) improves proteome-wide N-homocysteinylation mapping in mouse liver and brain proteins
N -Homocysteinylation induces immunogenic, thrombogenic, and amyloidogenic properties of proteins. Although important to gain insight into the mechanisms of homocysteine (Hcy) toxicity, proteome-wide studies of the effects of Hcy-thiolactone (HTL) protein modification remain challenging due to the low abundance of N -Hcy-proteins. High-field asymmetric waveform ion mobility spectrometry (FAIMS), as a robust online fractionation method, improves the identification of other PTMs, we therefore expected it to facilitate the detection of N -homocysteinylated proteins ( N -Hcy-proteins) and help gain insight into their role in human disease. After extensive measurement optimization, we compared the yield of N -Hcy-protein/peptide identification across mouse liver and brain samples, either native or modified in vitro with HTL. Additionally, we examined the influence of different thiol reduction and blocking agents, namely dithiothreitol (DTT)/iodoacetamide (IAA) and tris(2-carboxyethyl)phosphine (TCEP)/methyl methanethiosulfonate (MMTS), on the number of identified N -Hcy-sites. FAIMS increased the number of N -Hcy-Lys-peptides and N -Hcy-proteins by 1.3–7-fold and 1.1–7-fold, respectively, and was on average higher with the usage of TCEP/MMTS thiol reduction/blocking method. We have identified 69 and 1198 in vivo and in vitro N -Hcy-proteins, respectively. We conclude that FAIMS is a valuable addition to N -Hcy-proteome analysis workflow and facilitates the mapping of N -Hcy-sites. Data are available via ProteomeXchange with identifier PXD062860.
- 3 August 2026
- Published by Springer Nature in Amino Acids
Open AccessHigh-field asymmetric waveform ion mobility spectrometry (FAIMS) improves proteome-wide N-homocysteinylation mapping in mouse liver and brain proteins
N -Homocysteinylation induces immunogenic, thrombogenic, and amyloidogenic properties of proteins. Although important to gain insight into the mechanisms of homocysteine (Hcy) toxicity, proteome-wide studies of the effects of Hcy-thiolactone (HTL) protein modification remain challenging due to the low abundance of N -Hcy-proteins. High-field asymmetric waveform ion mobility spectrometry (FAIMS), as a robust online fractionation method, improves the identification of other PTMs, we therefore expected it to facilitate the detection of N -homocysteinylated proteins ( N -Hcy-proteins) and help gain insight into their role in human disease. After extensive measurement optimization, we compared the yield of N -Hcy-protein/peptide identification across mouse liver and brain samples, either native or modified in vitro with HTL. Additionally, we examined the influence of different thiol reduction and blocking agents, namely dithiothreitol (DTT)/iodoacetamide (IAA) and tris(2-carboxyethyl)phosphine (TCEP)/methyl methanethiosulfonate (MMTS), on the number of identified N -Hcy-sites. FAIMS increased the number of N -Hcy-Lys-peptides and N -Hcy-proteins by 1.3–7-fold and 1.1–7-fold, respectively, and was on average higher with the usage of TCEP/MMTS thiol reduction/blocking method. We have identified 69 and 1198 in vivo and in vitro N -Hcy-proteins, respectively. We conclude that FAIMS is a valuable addition to N -Hcy-proteome analysis workflow and facilitates the mapping of N -Hcy-sites. Data are available via ProteomeXchange with identifier PXD062860.
- Open Access
High field asymmetric waveform ion mobility spectrometry improves N -homocysteinylation mapping in mouse liver and brain proteins
N -Homocysteinylation has been shown to induce immunogenic, thrombogenic, and amyloidogenic properties of proteins. Although very important to gain insight into the mechanisms of homocysteine (Hcy) toxicity, proteome-wide studies of the effects of Hcy-thiolactone (HTL) protein modification remain challenging due to the low abundance of N -Hcy-proteins. High field asymmetric waveform ion mobility spectrometry (FAIMS) has been shown to improve the identification of other PTMs, we therefore expected it to facilitate the characterization of N -homocysteinylated proteins ( N -Hcy-proteins) and help gain insight into their role in human disease. After extensive measurement optimization, we compared the yield of N -Hcy-protein/peptide identification across mouse liver and brain samples, either native or modified in vitro with HTL. Additionally, we examined the influence of different reduction and alkylation agents, namely DTT/IAA and TCEP/MMTS, on the number of identified N -Hcy-sites. FAIMS increased the number of N -Hcy-Lys-peptides and N -Hcy-proteins by 1.3-7-fold and 1.1-14-fold, respectively, regardless of alkylation method. We have identified 69 and 1,198 in vivo and in vitro N -Hcy-proteins, respectively. KEGG pathway term enrichment analysis showed that among in vitro N -Hcy-proteins, ten top KEGG pathways were Parkinson disease, prion disease, Huntington disease, oxidative phosphorylation, amyotrophic lateral sclerosis, pathways of neurodegeneration – multiple diseases, carbon metabolism, carcinogenesis – reactive oxygen species, Alzheimer disease, and diabetic cardiomyopathy. We conclude that FAIMS is a valuable addition to N -Hcy-proteome analysis workflow and facilitates the mapping of N -Hcy-sites. Data are available via ProteomeXchange with identifier PXD062860.
Open AccessHigh field asymmetric waveform ion mobility spectrometry improves N -homocysteinylation mapping in mouse liver and brain proteins
N -Homocysteinylation has been shown to induce immunogenic, thrombogenic, and amyloidogenic properties of proteins. Although very important to gain insight into the mechanisms of homocysteine (Hcy) toxicity, proteome-wide studies of the effects of Hcy-thiolactone (HTL) protein modification remain challenging due to the low abundance of N -Hcy-proteins. High field asymmetric waveform ion mobility spectrometry (FAIMS) has been shown to improve the identification of other PTMs, we therefore expected it to facilitate the characterization of N -homocysteinylated proteins ( N -Hcy-proteins) and help gain insight into their role in human disease. After extensive measurement optimization, we compared the yield of N -Hcy-protein/peptide identification across mouse liver and brain samples, either native or modified in vitro with HTL. Additionally, we examined the influence of different reduction and alkylation agents, namely DTT/IAA and TCEP/MMTS, on the number of identified N -Hcy-sites. FAIMS increased the number of N -Hcy-Lys-peptides and N -Hcy-proteins by 1.3-7-fold and 1.1-14-fold, respectively, regardless of alkylation method. We have identified 69 and 1,198 in vivo and in vitro N -Hcy-proteins, respectively. KEGG pathway term enrichment analysis showed that among in vitro N -Hcy-proteins, ten top KEGG pathways were Parkinson disease, prion disease, Huntington disease, oxidative phosphorylation, amyotrophic lateral sclerosis, pathways of neurodegeneration – multiple diseases, carbon metabolism, carcinogenesis – reactive oxygen species, Alzheimer disease, and diabetic cardiomyopathy. We conclude that FAIMS is a valuable addition to N -Hcy-proteome analysis workflow and facilitates the mapping of N -Hcy-sites. Data are available via ProteomeXchange with identifier PXD062860.
- Open Access
- 17 September 2024
- Published by Polskie Towarzystwo Biochemiczne (Polish Biochemical Society) in Postępy Biochemii
- Vol. 70 (3) , 336-347
Histony łącznikowe H1 w chorobach człowieka
Linker histones (H1) are basic proteins that are part of the nucleosome structure in the cell nucleus and are involved in the packaging of genetic material and the regulation of gene expression. As research progressed, it was discovered that linker histones constitute the largest group of histones in terms of variants found in humans. Even though the H1 variants differ slightly in the primary structure, they can perform different functions, undergo multiple post-translational modifications and differ in cellular localization. In addition to the nucleus, histones H1 can occur in the cytoplasm, on the cell surface and in the intercellular space. In these places, they play a supporting role for the immune system and act as signaling molecules. Changes in the levels of histones and their post-translational modifications have been associated with many human diseases and it is postulated that some of them may serve as biomarkers or therapeutic targets.
- 17 September 2024
- Published by Polskie Towarzystwo Biochemiczne (Polish Biochemical Society) in Postępy Biochemii
- Vol. 70 (3) , 336-347
Open AccessHistony łącznikowe H1 w chorobach człowieka
Linker histones (H1) are basic proteins that are part of the nucleosome structure in the cell nucleus and are involved in the packaging of genetic material and the regulation of gene expression. As research progressed, it was discovered that linker histones constitute the largest group of histones in terms of variants found in humans. Even though the H1 variants differ slightly in the primary structure, they can perform different functions, undergo multiple post-translational modifications and differ in cellular localization. In addition to the nucleus, histones H1 can occur in the cytoplasm, on the cell surface and in the intercellular space. In these places, they play a supporting role for the immune system and act as signaling molecules. Changes in the levels of histones and their post-translational modifications have been associated with many human diseases and it is postulated that some of them may serve as biomarkers or therapeutic targets.
- 24 June 2024
- Published by Elsevier in Food Hydrocolloids
- Vol. 156
Characterization of hemp seed oil emulsion stabilized by soap nuts (Sapindus mukorossi) extract
- 24 June 2024
- Published by Elsevier in Food Hydrocolloids
- Vol. 156
Characterization of hemp seed oil emulsion stabilized by soap nuts (Sapindus mukorossi) extract
- Open Access
Association of Metallic and Nonmetallic Elements with Fibrin Clot Properties and Ischemic Stroke
Objectives—Metallic elements and fibrin clot properties have been linked to stroke. We examined metallic and nonmetallic elements, fibrin clot lysis time (CLT), and maximum absorbance (Absmax) in relation to ischemic stroke. Design—A case–control study of ischemic stroke patients vs. healthy individuals. Subjects and Methods—Plasma and serum were collected from 260 ischemic stroke patients (45.0% women; age, 68 ± 12 years) and 291 healthy controls (59.7% women; age, 50 ± 17 years). Fibrin CLT and Absmax were measured using a validated turbidimetric assay. Serum elements were quantified by inductively coupled plasma mass spectrometry (ICP-MS) and optical emission spectrometry (ICP-OES). Data were analyzed by bivariate correlations and multiple or logistic regression. Results—In female stroke patients, copper, lithium, and aluminum were significantly lower compared with controls; in male stroke patients, potassium was lower, and beryllium was elevated. In female and male stroke patients, iron, zinc, nickel, calcium, magnesium, sodium, and silicon were significantly lower, while strontium was elevated. Positive correlations between fibrin clot properties and metals, observed in healthy controls, were lost in ischemic stroke patients. In multivariate regression analysis, fibrin CLT and/or Absmax was associated with zinc, calcium, potassium, beryllium, and silicon in stroke patients and with sodium, potassium, beryllium, and aluminum in controls. In logistic regression analysis, stroke was independently associated with lithium, nickel, beryllium, strontium, boron, and silicon and with sodium, potassium, calcium, and aluminum but not with fibrin CLT/Absmax. Conclusions—Various elements were associated with fibrin clot properties and the risk of ischemic stroke. Lithium, sodium, calcium, and aluminum abrogated the association of fibrin clot properties with ischemic stroke.
Open AccessAssociation of Metallic and Nonmetallic Elements with Fibrin Clot Properties and Ischemic Stroke
Objectives—Metallic elements and fibrin clot properties have been linked to stroke. We examined metallic and nonmetallic elements, fibrin clot lysis time (CLT), and maximum absorbance (Absmax) in relation to ischemic stroke. Design—A case–control study of ischemic stroke patients vs. healthy individuals. Subjects and Methods—Plasma and serum were collected from 260 ischemic stroke patients (45.0% women; age, 68 ± 12 years) and 291 healthy controls (59.7% women; age, 50 ± 17 years). Fibrin CLT and Absmax were measured using a validated turbidimetric assay. Serum elements were quantified by inductively coupled plasma mass spectrometry (ICP-MS) and optical emission spectrometry (ICP-OES). Data were analyzed by bivariate correlations and multiple or logistic regression. Results—In female stroke patients, copper, lithium, and aluminum were significantly lower compared with controls; in male stroke patients, potassium was lower, and beryllium was elevated. In female and male stroke patients, iron, zinc, nickel, calcium, magnesium, sodium, and silicon were significantly lower, while strontium was elevated. Positive correlations between fibrin clot properties and metals, observed in healthy controls, were lost in ischemic stroke patients. In multivariate regression analysis, fibrin CLT and/or Absmax was associated with zinc, calcium, potassium, beryllium, and silicon in stroke patients and with sodium, potassium, beryllium, and aluminum in controls. In logistic regression analysis, stroke was independently associated with lithium, nickel, beryllium, strontium, boron, and silicon and with sodium, potassium, calcium, and aluminum but not with fibrin CLT/Absmax. Conclusions—Various elements were associated with fibrin clot properties and the risk of ischemic stroke. Lithium, sodium, calcium, and aluminum abrogated the association of fibrin clot properties with ischemic stroke.
- Open Access
- 10 April 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (8) , 4181
COVID-19 and One-Carbon Metabolism
Dysregulation of one-carbon metabolism affects a wide range of biological processes and is associated with a number of diseases, including cardiovascular disease, dementia, neural tube defects, and cancer. Accumulating evidence suggests that one-carbon metabolism plays an important role in COVID-19. The symptoms of long COVID-19 are similar to those presented by subjects suffering from vitamin B12 deficiency (pernicious anemia). The metabolism of a cell infected by the SARS-CoV-2 virus is reshaped to fulfill the need for massive viral RNA synthesis, which requires de novo purine biosynthesis involving folate and one-carbon metabolism. Many aspects of host sulfur amino acid metabolism, particularly glutathione metabolism underlying antioxidant defenses, are also taken over by the SARS-CoV-2 virus. The purpose of this review is to summarize recent findings related to one-carbon metabolism and sulfur metabolites in COVID-19 and discuss how they inform strategies to combat the disease.
- 10 April 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (8) , 4181
Open AccessCOVID-19 and One-Carbon Metabolism
Dysregulation of one-carbon metabolism affects a wide range of biological processes and is associated with a number of diseases, including cardiovascular disease, dementia, neural tube defects, and cancer. Accumulating evidence suggests that one-carbon metabolism plays an important role in COVID-19. The symptoms of long COVID-19 are similar to those presented by subjects suffering from vitamin B12 deficiency (pernicious anemia). The metabolism of a cell infected by the SARS-CoV-2 virus is reshaped to fulfill the need for massive viral RNA synthesis, which requires de novo purine biosynthesis involving folate and one-carbon metabolism. Many aspects of host sulfur amino acid metabolism, particularly glutathione metabolism underlying antioxidant defenses, are also taken over by the SARS-CoV-2 virus. The purpose of this review is to summarize recent findings related to one-carbon metabolism and sulfur metabolites in COVID-19 and discuss how they inform strategies to combat the disease.
- 2 April 2021
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 20 (5) , 2458-2476
Proteome-Wide Analysis of Protein Lysine N-Homocysteinylation in Saccharomyces cerevisiae
Protein N-homocysteinylation by a homocysteine (Hcy) metabolite, Hcy-thiolactone, is an emerging post-translational modification (PTM) that occurs in all tested organisms and has been linked to human diseases. The yeast Saccharomyces cerevisiae is widely used as a model eukaryotic organism in biomedical research, including studies of protein PTMs. However, patterns of global protein N-homocysteinylation in yeast are not known. Here, we identified 68 in vivo and 197 in vitro N-homocysteinylation sites at protein lysine residues (N-Hcy-Lys). Some of the N-homocysteinylation sites overlap with other previously identified PTM sites. Protein N-homocysteinylation in vivo, induced by supplementation of yeast cultures with Hcy, which elevates Hcy-thiolactone levels, was accompanied by significant changes in the levels of 70 yeast proteins (38 up-regulated and 32 down-regulated) involved in the ribosomal structure, amino acid biosynthesis, and basic cellular pathways. Our study provides the first global survey of N-homocysteinylation and accompanying changes in the yeast proteome caused by elevated Hcy level. These findings suggest that protein N-homocysteinylation and dysregulation of cellular proteostasis may contribute to the toxicity of Hcy in yeast. Homologous proteins and N-homocysteinylation sites are likely to be involved in Hcy-related pathophysiology in humans and experimental animals. Data are available via ProteomeXchange with identifier PXD020821.
- 2 April 2021
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 20 (5) , 2458-2476
Proteome-Wide Analysis of Protein Lysine N-Homocysteinylation in Saccharomyces cerevisiae
Protein N-homocysteinylation by a homocysteine (Hcy) metabolite, Hcy-thiolactone, is an emerging post-translational modification (PTM) that occurs in all tested organisms and has been linked to human diseases. The yeast Saccharomyces cerevisiae is widely used as a model eukaryotic organism in biomedical research, including studies of protein PTMs. However, patterns of global protein N-homocysteinylation in yeast are not known. Here, we identified 68 in vivo and 197 in vitro N-homocysteinylation sites at protein lysine residues (N-Hcy-Lys). Some of the N-homocysteinylation sites overlap with other previously identified PTM sites. Protein N-homocysteinylation in vivo, induced by supplementation of yeast cultures with Hcy, which elevates Hcy-thiolactone levels, was accompanied by significant changes in the levels of 70 yeast proteins (38 up-regulated and 32 down-regulated) involved in the ribosomal structure, amino acid biosynthesis, and basic cellular pathways. Our study provides the first global survey of N-homocysteinylation and accompanying changes in the yeast proteome caused by elevated Hcy level. These findings suggest that protein N-homocysteinylation and dysregulation of cellular proteostasis may contribute to the toxicity of Hcy in yeast. Homologous proteins and N-homocysteinylation sites are likely to be involved in Hcy-related pathophysiology in humans and experimental animals. Data are available via ProteomeXchange with identifier PXD020821.
- Open Access
- 28 November 2020
- Published by MDPI AG in Antioxidants
- Vol. 9 (12) , 1198
Genetic Attenuation of Paraoxonase 1 Activity Induces Proatherogenic Changes in Plasma Proteomes of Mice and Humans
High-density lipoprotein (HDL), in addition to promoting reverse cholesterol transport, possesses anti-inflammatory, antioxidative, and antithrombotic activities. Paraoxonase 1 (PON1), carried on HDL in the blood, can contribute to these antiatherogenic activities. The PON1-Q192R polymorphism involves a change from glutamine (Q variant) to arginine (R variant) at position 192 of the PON1 protein and affects its enzymatic activity. The molecular basis of PON1 association with cardiovascular and neurological diseases is not fully understood. To get insight into the function of PON1 in human disease, we examined how genetic attenuation of PON1 levels/activity affect plasma proteomes of mice and humans. Healthy participants (48.9 years old, 50% women) were randomly recruited from the Poznań population. Four-month-old Pon1−/− (n = 17) and Pon1+/+ (n = 8) mice (50% female) were used in these experiments. Plasma proteomes were analyzed using label-free mass spectrometry. Bioinformatics analysis was carried out using the Ingenuity Pathway Analysis (IPA) resources. PON1-Q192R polymorphism and Pon1−/− genotype induced similar changes in plasma proteomes of humans and mice, respectively. The top molecular network, identified by IPA, affected by these changes involved proteins participating in lipoprotein metabolism. Other PON1 genotype-dependent proteomic changes affect different biological networks in humans and mice: “cardiovascular, neurological disease, organismal injury/abnormalities” in PON1-192QQ humans and “humoral immune response, inflammatory response, protein synthesis” and “cell-to-cell signaling/interaction, hematological system development/function, immune cell trafficking” in Pon1−/− mice. Our findings suggest that PON1 interacts with molecular pathways involved in lipoprotein metabolism, acute/inflammatory response, and complement/blood coagulation that are essential for blood homeostasis. Modulation of those interactions by the PON1 genotype can account for its association with cardiovascular and neurological diseases.
- 28 November 2020
- Published by MDPI AG in Antioxidants
- Vol. 9 (12) , 1198
Open AccessGenetic Attenuation of Paraoxonase 1 Activity Induces Proatherogenic Changes in Plasma Proteomes of Mice and Humans
High-density lipoprotein (HDL), in addition to promoting reverse cholesterol transport, possesses anti-inflammatory, antioxidative, and antithrombotic activities. Paraoxonase 1 (PON1), carried on HDL in the blood, can contribute to these antiatherogenic activities. The PON1-Q192R polymorphism involves a change from glutamine (Q variant) to arginine (R variant) at position 192 of the PON1 protein and affects its enzymatic activity. The molecular basis of PON1 association with cardiovascular and neurological diseases is not fully understood. To get insight into the function of PON1 in human disease, we examined how genetic attenuation of PON1 levels/activity affect plasma proteomes of mice and humans. Healthy participants (48.9 years old, 50% women) were randomly recruited from the Poznań population. Four-month-old Pon1−/− (n = 17) and Pon1+/+ (n = 8) mice (50% female) were used in these experiments. Plasma proteomes were analyzed using label-free mass spectrometry. Bioinformatics analysis was carried out using the Ingenuity Pathway Analysis (IPA) resources. PON1-Q192R polymorphism and Pon1−/− genotype induced similar changes in plasma proteomes of humans and mice, respectively. The top molecular network, identified by IPA, affected by these changes involved proteins participating in lipoprotein metabolism. Other PON1 genotype-dependent proteomic changes affect different biological networks in humans and mice: “cardiovascular, neurological disease, organismal injury/abnormalities” in PON1-192QQ humans and “humoral immune response, inflammatory response, protein synthesis” and “cell-to-cell signaling/interaction, hematological system development/function, immune cell trafficking” in Pon1−/− mice. Our findings suggest that PON1 interacts with molecular pathways involved in lipoprotein metabolism, acute/inflammatory response, and complement/blood coagulation that are essential for blood homeostasis. Modulation of those interactions by the PON1 genotype can account for its association with cardiovascular and neurological diseases.
- 1 November 2020
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 160, 219-226
Telomere length and mtDNA copy number in human cystathionine β-synthase deficiency
- 1 November 2020
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 160, 219-226
Telomere length and mtDNA copy number in human cystathionine β-synthase deficiency
- Open Access
- 5 April 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (7) , 2520
The Cbs Locus Affects the Expression of Senescence Markers and mtDNA Copy Number, but not Telomere Dynamics in Mice
Cystathionine β-synthase (CBS) is a housekeeping enzyme that catalyzes the first step of the homocysteine to cysteine transsulfuration pathway. Homozygous deletion of the Cbs gene in mice causes severe hyperhomocysteinemia and reduces life span. Here, we examined a possible involvement of senescence, mitochondrial DNA, and telomeres in the reduced life span of Cbs−/− mice. We found that senescence-related p21, Pai-1, Mcp1, and Il-6 mRNAs were significantly upregulated (2–10-fold) in liver, while p21 was upregulated in the brain of Cbs−/− mice (n = 20) compared with control Cbs+/− siblings (n = 20) in a sex- and age-dependent manner. Telomere length in blood (n = 80), liver (n = 40), and brain (n = 40) was not affected by the Cbs−/− genotype, but varied with sex and/or age. Levels of mitochondrial DNA tended to be reduced in livers, but not brains and blood, of Cbs−/− females (n = 20–40). The Cbs−/− genotype significantly reduced Tert mRNA expression in brain, but not liver, in a sex- and age-dependent manner. Multiple regression analysis showed that the senescence-related liver (but not brain) mRNAs and liver (but not brain or blood) mitochondrial DNA were associated with the Cbs genotype. In contrast, telomere length in blood, brain, and liver was not associated with the Cbs genotype or hyperhomocysteinemia, but was associated with sex (in brain and liver) and age (in brain and blood). Taken together, these findings suggest that the changes in senescence marker expression and mtDNA levels, but not telomere shortening, could account for the reduced life span of Cbs−/− mice.
- 5 April 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (7) , 2520
Open AccessThe Cbs Locus Affects the Expression of Senescence Markers and mtDNA Copy Number, but not Telomere Dynamics in Mice
Cystathionine β-synthase (CBS) is a housekeeping enzyme that catalyzes the first step of the homocysteine to cysteine transsulfuration pathway. Homozygous deletion of the Cbs gene in mice causes severe hyperhomocysteinemia and reduces life span. Here, we examined a possible involvement of senescence, mitochondrial DNA, and telomeres in the reduced life span of Cbs−/− mice. We found that senescence-related p21, Pai-1, Mcp1, and Il-6 mRNAs were significantly upregulated (2–10-fold) in liver, while p21 was upregulated in the brain of Cbs−/− mice (n = 20) compared with control Cbs+/− siblings (n = 20) in a sex- and age-dependent manner. Telomere length in blood (n = 80), liver (n = 40), and brain (n = 40) was not affected by the Cbs−/− genotype, but varied with sex and/or age. Levels of mitochondrial DNA tended to be reduced in livers, but not brains and blood, of Cbs−/− females (n = 20–40). The Cbs−/− genotype significantly reduced Tert mRNA expression in brain, but not liver, in a sex- and age-dependent manner. Multiple regression analysis showed that the senescence-related liver (but not brain) mRNAs and liver (but not brain or blood) mitochondrial DNA were associated with the Cbs genotype. In contrast, telomere length in blood, brain, and liver was not associated with the Cbs genotype or hyperhomocysteinemia, but was associated with sex (in brain and liver) and age (in brain and blood). Taken together, these findings suggest that the changes in senescence marker expression and mtDNA levels, but not telomere shortening, could account for the reduced life span of Cbs−/− mice.